0
0
March 1, 2025 – Medical experts have announced that fat-derived cellular concentrate is showing significant promise as a potential treatment for individuals with uncontrolled diabetes who rely on insulin. This development offers hope for millions struggling with the disease, particularly in India, where diabetes prevalence is alarmingly high.
India faces a substantial diabetes burden, with approximately 100 million people living with the condition and another 135 million in a prediabetic state. This makes innovative treatment approaches crucial.
In 2022, a government hospital in Kanpur, Uttar Pradesh, achieved a medical milestone by performing India’s first fat-derived stem cell transplant for diabetes. The procedure involves extracting stem cells from fat tissue in the waist and abdomen and then injecting them into the patient’s muscles and blood cells. This process aims to stimulate the pancreas to release normal levels of insulin.
The first recipient of this stem cell transplant was a 50-year-old man. Notably, his HbA1c levels, a key indicator of long-term blood sugar control, decreased from 10 to 6.5 within six months, without any significant changes to his lifestyle or diet.
Experts believe this method has the potential to effectively manage uncontrolled diabetes and mitigate associated complications, such as nerve and kidney damage, as well as heart issues. However, concerns remain regarding the high costs associated with creating beta cells from induced pluripotent stem cells and the potential for long-term immune system rejection.
The fat-derived cellular concentrate approach offers a potentially more accessible and less invasive alternative for managing diabetes. Further research and clinical trials are necessary to fully evaluate its long-term efficacy and safety.
Disclaimer: This news article is based on information available at the time of publication and reflects early findings and expert opinions. Medical research is ongoing, and further studies are needed to confirm these results and establish fat-derived cellular concentrate as a standard treatment for diabetes. This article is for informational purposes only and does not constitute medical advice. Individuals with diabetes or concerns about their health should consult with a qualified healthcare provider for diagnosis and treatment. Stem cell treatments are still in development and have not been fully approved by all regulatory bodies.
